VIMSELTINIB
Total Payments
$173,161
Transactions
276
Doctors
56
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $173,161 | 276 | 56 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $130,900 | 59 | 75.6% |
| Travel and Lodging | $33,150 | 104 | 19.1% |
| Food and Beverage | $9,111 | 113 | 5.3% |
Top Doctors Receiving Payments for VIMSELTINIB — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | Lisle, IL | $1,882 | 3 |
| , M.D | Hematology & Oncology | Milwaukee, WI | $1,847 | 3 |
| , MD | Hematology & Oncology | Scottsdale, AZ | $1,665 | 1 |
| , NP-BC | Nurse Practitioner | New Brunswick, NJ | $1,502 | 5 |
| , MD | Obstetrics & Gynecology | Murray, UT | $923.03 | 4 |
| , MD | Orthopaedic Surgery | Saint Louis, MO | $844.51 | 4 |
Ad
Manufacturing Companies
- Deciphera Pharmaceuticals Inc. $173,161
Product Information
- Type Drug
- Total Payments $173,161
- Total Doctors 56
- Transactions 276
About VIMSELTINIB
VIMSELTINIB is a drug associated with $173,161 in payments to 56 healthcare providers, recorded across 276 transactions in the CMS Open Payments database. The primary manufacturer is Deciphera Pharmaceuticals Inc..
Payment data is available from 2024 to 2024. In 2024, $173,161 was paid across 276 transactions to 56 doctors.
The most common payment nature for VIMSELTINIB is "Honoraria" ($130,900, 75.6% of total).